Today: 30 April 2026
Carvana stock jumps 7% as insider-sale filings hit; what CVNA investors watch next
6 January 2026
1 min read

Carvana stock jumps 7% as insider-sale filings hit; what CVNA investors watch next

New York, January 5, 2026, 19:44 EST — After-hours

Carvana Co shares rose 7.5% to $430.06 on Monday. The stock traded between $400.06 and $434.38, keeping the $400 level in view as a near-term chart support area.

The online used-car retailer has been a closely watched momentum name since its late-2025 addition to the S&P 500, a shift that can increase the stock’s visibility and the impact of index-linked flows.

That spotlight matters now with investors resetting positions for 2026 and looking for the next data point that can confirm — or challenge — expectations baked into the stock’s valuation.

A Form 4 filed on Monday showed Chief Financial Officer Mark Jenkins exercised options and sold 12,750 Class A shares on Jan. 2 at prices listed between about $391 and $420. The sale totaled about $5.14 million at a weighted average near $403, based on the transaction prices in the filing, and the document said the trades were made under a Rule 10b5-1 plan adopted in August 2024.

A separate Form 4 showed Chief Operating Officer Benjamin Huston exercised options and sold 10,000 shares on Jan. 2 for about $4.02 million at a weighted average near $402. The filing said those sales were executed under a Rule 10b5-1 plan adopted in December 2024 — a pre-set trading program that lets insiders sell shares on a schedule.

Other Form 4s filed on Monday reflected tax-related share withholdings tied to vesting of restricted stock units, or stock awards that convert into shares over time. Chief Product Officer Daniel Gill and General Counsel Paul Breaux reported shares withheld to cover taxes on Jan. 1, the filings showed.

Carvana outperformed larger rival CarMax, whose shares gained 2.6% on Monday, as the S&P 500 ended up 0.6% on the day.

But the rally keeps focus on a key uncertainty: demand for used vehicles and the financing environment that supports purchases. Insider sales, even when pre-scheduled, can also sharpen debate around valuation when the stock is moving in wide daily ranges.

The next clear catalyst is earnings, with Wall Street expecting Carvana to report around Feb. 18, according to Zacks’ earnings calendar. Investors will watch retail units sold and gross profit per unit — a gauge of how much the company makes on each vehicle — along with any outlook on 2026 demand and credit conditions.

Stock Market Today

  • Starbucks Shares Seen as Overvalued After 32% Yearly Gain, DCF Model Indicates
    April 30, 2026, 8:51 AM EDT. Starbucks (SBUX) shares have surged 32.2% over the past year, reaching around $105.50. However, valuation metrics suggest caution. A Discounted Cash Flow (DCF) analysis, a method estimating present value of future cash flows, values the stock at approximately $63.21 per share, implying it is about 67% overvalued. Despite strong returns, Starbucks scores 0 out of 6 on key valuation checks, raising concerns about potential overpricing. The price-to-earnings (P/E) ratio and other valuation methods further question if current stock levels reflect realistic growth expectations amid evolving market dynamics. Investors may want to weigh these signals amid Starbucks' global brand strength and consumer service positioning.

Latest article

QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

30 April 2026
Qualcomm shares rose 10.3% premarket Thursday after CEO Cristiano Amon said the smartphone market had bottomed and highlighted progress in data-center chips. Fiscal Q2 revenue fell 3% to $10.6 billion, with handset revenue down 13% but automotive up 38%. The Q3 forecast missed Wall Street estimates. Qualcomm expects chip sales to Chinese handset makers to recover after Q3.
Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

30 April 2026
Eli Lilly raised its 2026 revenue forecast by $2 billion after first-quarter sales jumped 56% to $19.8 billion, driven by Mounjaro and Zepbound, which brought in $12.8 billion. Adjusted earnings reached $8.55 per share. The company cited strong demand but noted lower realized prices and competition from Novo Nordisk remain risks. Foundayo, Lilly’s new oral GLP-1 pill, launched in April but was not included in the quarter’s results.
CoreWeave stock (CRWV) slips after hours as Nvidia Rubin rollout plan lands
Previous Story

CoreWeave stock (CRWV) slips after hours as Nvidia Rubin rollout plan lands

Caterpillar stock jumps: what CAT plans to unveil with Nvidia at CES 2026
Next Story

Caterpillar stock jumps: what CAT plans to unveil with Nvidia at CES 2026

Go toTop